NCT01286311

Tailored Communication to Reduce Cardiovascular Risk

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 464 (actual)
• Sponsor: Northwestern University · Academic / Other
• Sex: All
• Age: 40 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

The primary goal of the trial is to test the feasibility and efficacy of a cardiovascular disease quality improvement system that couples EMR-based patient identification with individually tailored patient messages. The study will test the hypothesis that that a tailored patient-directed approach to cardiovascular risk reduction integrated into patients' primary care delivery site will improve control of elevated low-density lipoprotein cholesterol and other card iac risk factors more than routine care alone for patients at intermediate or high risk for cardiovascular disease.

Conditions

• Hypercholesterolemia
• Coronary Artery Disease
• Dyslipidemia
• Hypertension

Interventions

Type	Name	Description
BEHAVIORAL	Direct-to-patient tailored cardiovascular risk message system	Patient informational mailings

Timeline

• Start date: 2011-01-01
• Primary completion: 2013-01-01
• Completion: 2013-01-01
• First posted: 2011-01-31
• Last updated: 2015-02-09
• Results posted: 2015-02-09

Locations

1 site across 1 country: United States